Ppd Development, Lp

Austin, Texas 78744-1645

2 studies enrolling now · 59 studies all time

What they study most

Alzheimer Disease, Anemia, Sickle Cell, Arthritis, Rheumatoid, Diabetes, Diabetes Mellitus, Health Participants, Health, Subjective, Healthy, Healthy Adult Volunteers, Healthy Participants, Healthy Volunteer, Healthy Volunteers

Studies at this site

• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) — Recruiting now
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Recruiting now
• A Study of Oral E1018 in Healthy Adult Participants — Running, not enrolling
• This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants — Completed
• A Study to Investigate the Absorption, Metabolism and Excretion of [14C]-BGB-11417 — Completed
• A Study of TAK-105 in Healthy Adults — Completed
• A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease — Completed
• A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants — Completed
• A Study of TAK-510 in Healthy Adults — Completed
• A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia — Stopped early
• A Study of the Cardiac Effects of ALXN1840 in Healthy Adults — Completed
• Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants — Completed
• A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants — Completed
• A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants — Completed
• A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants — Completed
• A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time — Completed
• A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects — Completed
• Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers — Completed
• A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants — Completed
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants — Completed
• To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17 — Completed
• A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes — Completed
• A Safety Study of ARRY-300 in Healthy Subjects — Completed
• Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers — Completed
• Bioavailability of Enasidenib (CC-90007) Sprinkle Formulation Relative to the Reference Tablet Formulation and Effect of Food on the Pharmacokinetics of Sprinkle Formulation in Healthy Adults — Completed
• Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules — Completed
• Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis — Stopped early
• CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects — Completed
• Study of CVN424 in Healthy Subjects — Completed
• Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults — Completed
• Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults. — Completed
• Efficacy Of PF-05089771 In Treating Postoperative Dental Pain — Completed
• Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers — Completed
• Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin — Completed
• Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers — Completed
• Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects — Completed
• Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects — Completed
• Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects — Completed
• Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects — Completed
• Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State — Completed
• Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects — Completed
• A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates — Completed
• A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin — Completed
• A Study to Evaluate the Effect of Mipomersen on Cardiac Repolarization Conducted in Healthy Subjects — Completed
• Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects — Completed
• Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120 — Completed
• Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN) — Completed
• Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants — Completed
• Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR — Completed